Immune Checkpoint Inhibitors Intrathecal Injection in Patients With Leptomeningeal Metastases in NSCLC
Clinical trial NCT06132698 · RECRUITING
Trial details
- NCT number
- NCT06132698
- Sponsor
- West China Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-30
- Primary completion
- 2026-05-30
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.